US OptionsDetailed Quotes
AMED250117P85000
- 0.10
- 0.000.00%
15min DelayClose Jan 3 16:00 ET
0.00High0.00Low
0.10Open0.10Pre Close0 Volume1.62K Open Interest85.00Strike Price0.00Turnover24.83%IV6.99%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier12DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.0549Delta0.0264Gamma912.80Leverage Ratio-0.0175Theta-0.0016Rho-50.12Eff Leverage0.0188Vega
Amedisys Stock Discussion
Sign in to post a comment
$Amedisys (AMED.US)$ divergency with good fundamental Also gap so it looks good and risk to rewards is acceptable
1
$Inhibikase Therapeutics (IKT.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
2
No comment yet
Kofi : Do u see it going above 100 ?